Nucleotide precursors, nucleotide analogs and oligomeric compounds containing the same Grant US-11897911-B2 United States of America 13 Feb 2024
Compositions for the treatment of pathogenic- and/or chemical-induced lung injury and for… Grant US-11883401-B2 United States of America 30 Jan 2024
Methods of delivering anionic agents in vivo using non-viral nanoparticle-based delivery… Grant US-11766486-B2 United States of America 26 Sep 2023
Lipid-based nanoparticles for encapsulation and sustained release of therapeutic agents Grant US-11529314-B2 United States of America 20 Dec 2022
Treatment of hepatotoxicity with IL-11 antibody Grant US-11319368-B2 United States of America 03 May 2022
Composition for gene delivery comprising chitosan and liquid crystal formation material Grant US-11318215-B2 United States of America 03 May 2022
DELIVERY OF BIOMOLECULES TO IMMUNE CELLS Application US-20220064584-A1 United States of America 03 Mar 2022
Methods, compositions, and systems for delivering therapeutic and diagnostic agents into… Grant US-11219634-B2 United States of America 11 Jan 2022
Surfactant assisted formation of a catalyst complex for emulsion atom transfer radical… Grant US-11174325-B2 United States of America 16 Nov 2021
Treatment of fibrosis with Interleukin-11 receptor alpha antibody Grant US-10927169-B2 United States of America 23 Feb 2021
Treatment of fibrosis with interleukin-11 receptor alpha antibody Grant US-10899832-B2 United States of America 26 Jan 2021
Treatment of fibrosis with interleukin-11 receptor alpha antibody Grant US-10894826-B2 United States of America 19 Jan 2021
Treatment of fibrosis with interleukin-11 receptor alpha antibody Grant US-10894827-B2 United States of America 19 Jan 2021
Treatment of fibrosis with interleukin-11 antibody Grant US-10894825-B2 United States of America 19 Jan 2021
Treatment of fibrosis with interleukin-11 receptor alpha antibody Grant US-10889642-B2 United States of America 12 Jan 2021
Treatment of fibrosis with interleukin-11 antibody Grant US-10870697-B2 United States of America 22 Dec 2020
Treatment of fibrosis with interleukin-11 antibody Grant US-10870696-B2 United States of America 22 Dec 2020
Treatment of fibrosis with interleukin-11 antibody Grant US-10865241-B2 United States of America 15 Dec 2020
Treatment of fibrosis with interleukin-11 antibody Grant US-10865240-B2 United States of America 15 Dec 2020
Treatment of fibrosis with interleukin-11 antibody Grant US-10865239-B2 United States of America 15 Dec 2020
Treatment of fibrosis with IL-11 receptor alpha antibody Grant US-10822405-B2 United States of America 03 Nov 2020
Method of making peptide-tagged PEGylated chitosan nanoparticles Grant US-10799601-B2 United States of America 13 Oct 2020
RNAi molecule delivery platform based on single-siRNA and shRNA nanocapsules Grant US-10568844-B2 United States of America 25 Feb 2020
ANTIMICROBIAL PEPTIDE DERIVATIVE AND USE THEREOF Application US-20190216939-A1 United States of America 18 Jul 2019
Method for expressing, secreting and transferring functional microRNAs/siRNAs and… Application US-10308932-B2 United States of America 04 Jun 2019
Modulation of NLGn4 expression, NK cell activity in non-alcoholic fatty liver disease (NAFL… Grant US-10266897-B2 United States of America 23 Apr 2019
Atom transfer radical polymerization under biologically compatible conditions Grant US-10072042-B2 United States of America 11 Sep 2018
Aqueous ATRP in the presence of an activator regenerator Grant US-9982070-B2 United States of America 29 May 2018
Modulation of NLGn4 expression, NK cell activity in non-alcoholic fatty liver disease (NAFL… Grant US-9944988-B2 United States of America 17 Apr 2018
Methods of modifying a target nucleic acid with an argonaute Application US-9902973-B2 United States of America 27 Feb 2018
RNAi molecule delivery platform based on single-siRNA and shRNA nanocapsules Application US-9782357-B2 United States of America 10 Oct 2017
Signal activatable constructs and related components compositions methods and systems Grant US-9725715-B2 United States of America 08 Aug 2017
Electrochemically mediated atom transfer radical polymerization Grant US-9644042-B2 United States of America 09 May 2017
Modulation of NLGn4 expression, NK cell activity in non-alcoholic fatty liver disease (NAFL… Grant US-9469855-B2 United States of America 18 Oct 2016
MICROPARTICLE COMPRISING FUNCTIONAL MICRORNA/SIRNA AND APPLICATION THEREOF Application EP-2865393-A4 European Patent Office 23 Mar 2016
Modulation of NLGn4 expression, NK cell activity in non-alcoholic fatty liver disease (NAFL… Application US-9243294-B2 United States of America 26 Jan 2016
METHODS OF MODIFYING A TARGET NUCLEIC ACID WITH AN ARGONAUTE Application US-20150089681-A1 United States of America 26 Mar 2015
NON-VIRAL NANOPARTICLE-BASED DELIVERY SYSTEM Application US-20130337067-A1 United States of America 19 Dec 2013
A NOVEL RNAi MOLECULE DELIVERY PLATFORM BASED ON SINGLE-siRNA AND shRNA NANOCAPSULES Application WO-2013138783-A1 World Intellectual Property Organisation (WIPO) 19 Sep 2013
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HIV-1 INFECTIONS Application US-20130156791-A1 United States of America 20 Jun 2013